Skip to main content
Springer Nature Link
Log in

Impairment of stress granule assembly via inhibition of the eIF2alpha phosphorylation sensitizes glioma cells to chemotherapeutic agents

  • Laboratory Investigation
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Malignant gliomas are a lethal type of brain tumors that poorly respond to chemotherapeutic drugs. Several therapy resistance mechanisms have been characterized. However, the response to stress through mRNA translational control has not been evaluated for this type of tumor. A potential target would involve the alpha subunit of eukaryotic translation initiation factor (eIF2α) that leads to assembly of stress granules (SG) which are cytoplasmic granules mainly composed by RNA binding proteins and untranslated mRNAs. We assessed whether glioma cells are capable of assembling SG after exposure to different classes of chemotherapeutic agents through evaluation of the effects of interfering in this process by impairing the eIF2α signaling. C6 and U87MG cells were exposed to bortezomib, cisplatin, or etoposide. Forced expression of a dominant negative mutant of eIF2α (eIF2αDN) was employed to block this pathway. We observed that exposure to drugs stimulated SG assembly. This was reduced in eIF2αDN-transfected cells and this strategy enhanced chemotherapeutically-induced cell death for all drugs. Our data suggest that SG assembly occurs in glioma cells in response to chemotherapeutic drugs in an eIF2α-dependent manner and this response is relevant for drug resistance. Interfering with eIF2α signaling pathway may be a potential strategy for new co-adjuvant therapies to treat gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Huse JT, Holland EC (2010) Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 10:319–331

    Article  CAS  PubMed  Google Scholar 

  2. Dirks PB (2010) Brain tumor stem cells: the cancer stem cell hypothesis writ large. Mol Oncol 4:420–430

    Article  PubMed  Google Scholar 

  3. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

    Article  CAS  PubMed  Google Scholar 

  4. Lu C, Shervington A (2008) Chemoresistance in gliomas. Mol Cell Biochem 312:71–80

    Article  CAS  PubMed  Google Scholar 

  5. Sarkaria JN, Kitange GJ, James CD et al (2008) Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin Cancer Res 14:2900–2908

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Anderson P, Kedersha N (2009) RNA granules: post-transcriptional and epigenetic modulators of gene expression. Nat Rev Mol Cell Biol 10:430–436

    Article  CAS  PubMed  Google Scholar 

  7. Anderson P, Kedersha N (2008) Stress granules: the Tao of RNA triage. Trends Biochem Sci 33:141–150

    Article  CAS  PubMed  Google Scholar 

  8. Anderson P, Kedersha N (2002) Stressful initiations. J Cell Sci 15:3227–3234

    Google Scholar 

  9. Kedersha N, Ivanov P, Anderson P (2013) Stress granules and cell signaling: more than just a passing phase. Trends Biochem Sci 38:494–506

    Article  CAS  PubMed  Google Scholar 

  10. Fournier MJ, Gareau C, Mazroui R (2010) The chemotherapeutic agent bortezomib induces the formation of stress granules. Cancer Cell Int. doi:10.1186/1475-2867-10-12

    PubMed  PubMed Central  Google Scholar 

  11. Gareau C, Fournier MJ, Filion C et al (2011) p21(WAF1/CIP1) upregulation through the stress granule-associated protein CUGBP1 confers resistance to bortezomib-mediated apoptosis. PLoS ONE. doi:10.1371/journal.pone.0020254

    PubMed  PubMed Central  Google Scholar 

  12. Mazroui R, Di Marco S, Kaufman RJ, Gallouzi IE (2007) Inhibition of the ubiquitin-proteasome system induces stress granule formation. Mol Biol Cell 18:2603–2618

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Moreau P, Richardson PG, Cavo M et al (2012) Proteasome inhibitors in multiple myeloma: 10 years later. Blood 120:947–959

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Styczynski J, Olszewska-Slonina D, Kolodziej B et al (2006) Activity of bortezomib in glioblastoma. Anticancer Res 26:4499–4503

    CAS  PubMed  Google Scholar 

  15. Vlachostergios PJ, Hatzidaki E, Befani CD et al (2013) Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner. Inv New Drugs 31:1169–1181

    Article  CAS  Google Scholar 

  16. Vlachostergios PJ, Hatzidaki E, Stathakis NE et al (2013) Bortezomib downregulates MGMT expression in T98G glioblastoma cells. Cell Mol Neurobiol 33:313–318

    Article  CAS  PubMed  Google Scholar 

  17. Guo L, Chen R, Ma N et al (2013) Phosphorylation of eIF2α suppresses cisplatin-induced A549 cell apoptosis via p38 inhibition. Cancer Biother Radiopharm 28:268–273

    Article  CAS  PubMed  Google Scholar 

  18. Capdevila L, Cros S, Ramirez JL et al (2014) Neoadjuvant cisplatin plus temozolomide versus standard treatment in patients with unresectable glioblastoma or anaplastic astrocytoma: a differential effect of MGMT methylation. J Neurooncol 117:77–84

    Article  CAS  PubMed  Google Scholar 

  19. Aoki T, Mizutani T, Nojima K et al (2010) Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme. J Neurosurg 112:50–56

    Article  CAS  PubMed  Google Scholar 

  20. Kaufman RJ, Davies MV, Pathak VK, Hershey JWB (1989) The phosphorylation state of eukary9otic initiation factor 2 alters translational efficiency of specific mRNAs. Mol Cell Biol 9:946–958

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Sousa LP, Brasil BS, Silva BM et al (2005) Plasminogen/plasmin regulates c-fos and egr-1 expression via the MEK/ERK pathway. Biochem Biophys Res Commun 329:1065–1071

    Article  Google Scholar 

  22. Kedersha NL, Gupta M, Li W et al (1999) RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J Cell Biol 147:1431–1442

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Tourrière H, Chebli K, Zekri L et al (2003) The RasGAP-associated endoribonuclease G3BP assembles stress granules. J Cell Biol 160:823–831

    Article  PubMed  PubMed Central  Google Scholar 

  24. DuRose JB, Scheuner D, Kaufman RJ et al (2009) Phosphorylation of eukaryotic translation initiation factor 2alpha coordinates rRNA transcription and translation inhibition during endoplasmic reticulum stress. Mol Cell Biol 29:4295–4307

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Han J, Back SH, Hur J et al (2013) ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat Cell Biol 15:481–490

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Kouroku Y, Fujita E, Tanida I et al (2007) ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ 14:230–239

    Article  CAS  PubMed  Google Scholar 

  27. Gerlitz G, Jagus R, Elroy-Stein O (2002) Phosphorylation of initiation factor-2 alpha is required for activation of internal translation initiation during cell differentiation. Eur J Biochem 269:2810–2819

    Article  CAS  PubMed  Google Scholar 

  28. Teng Y, Gao M, Wang J et al (2014) Inhibition of eIF2α dephosphorylation enhances TRAIL-induced apoptosis in hepatoma cells. Cell Death Dis. doi:10.1038/cddis.2014.24

    Google Scholar 

  29. Vlachostergios PJ, Papandreou CN (2015) Efficacy of low dose temozolomide in combination with bortezomib in U87 glioma cells: a flow cytometric analysis. Arch Med Sci 11:307–310

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. Fabíola M. Ribeiro for the assistance with the Floid Imaging System equipment and Mrs. Ilma M. Souza for technical support. FASVB, KML, JPV and LFFB hold a CAPES PhD Scholarship. AED hold a CAPES Master Scholarship. LSB, AMS, LPS, DAG and MMT hold CNPq Research Fellowships. This work was supported by Pró-Reitoria de Pesquisa da UFMG (PRPq-UFMG), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Pesquisa (CNPq) and Fundação de Amparo à Pesquisa do estado de Minas Gerais (FAPEMIG).

Author information

Authors and Affiliations

  1. Department of Physiology and Biophysics, Biological Sciences Institute, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, 31270-901, Brazil

    Fabrício de Almeida Souza Vilas-Boas, Lucas Felipe Fernandes Bittencourt & Lucíola Silva Barcelos

  2. Department of Morphology, Biological Sciences Institute, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, 31270-901, Brazil

    Aristóbolo Mendes da Silva

  3. Department of Clinical and Toxicological Analysis, Pharmacy Faculty, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, 31270-901, Brazil

    Lirlândia Pires de Sousa, Kátia Maciel Lima & Juliana Priscila Vago

  4. Department of Biochemistry and Immunology, Biological Sciences Institute, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, 31270-901, Brazil

    Arthur Estanislau Dantas, Dawidson Assis Gomes & Mauro Martins Teixeira

  5. Department of Health Sciences, Federal University of Juiz de Fora—Advanced Campus, Governador Valadares, Minas Gerais, 35010-177, Brazil

    Márcia Carvalho Vilela

  6. Departamento de Fisiologia e Biofísica, Instituto de Ciências Biológicas (ICB), Universidade Federal of Minas Gerais (UFMG), Av. Antônio Carlos, 6627, Belo Horizonte, Minas Gerais, 31270-901, Brazil

    Lucíola Silva Barcelos

Authors
  1. Fabrício de Almeida Souza Vilas-Boas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aristóbolo Mendes da Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lirlândia Pires de Sousa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kátia Maciel Lima
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Juliana Priscila Vago
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lucas Felipe Fernandes Bittencourt
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Arthur Estanislau Dantas
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dawidson Assis Gomes
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Márcia Carvalho Vilela
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Mauro Martins Teixeira
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Lucíola Silva Barcelos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lucíola Silva Barcelos.

Ethics declarations

Conflicts of interest

The authors state that there are no competing interests.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 2909 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vilas-Boas, F., da Silva, A.M., de Sousa, L.P. et al. Impairment of stress granule assembly via inhibition of the eIF2alpha phosphorylation sensitizes glioma cells to chemotherapeutic agents. J Neurooncol 127, 253–260 (2016). https://doi.org/10.1007/s11060-015-2043-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-015-2043-3

Keywords

Search

Navigation